Prescription drug · NDA
Inbrija (levodopa) NDC 10144-342
Levodopa 42 mg/1 · Capsule · Respiratory (Inhalation) · Merz Pharmaceuticals, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 10144-342-04 | 10144034204 | 1 BLISTER PACK in 1 CARTON (10144-342-04) / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)Marketed from Aug 29, 2019 | |
| 10144-342-12 | 10144034212 | 3 BLISTER PACK in 1 CARTON (10144-342-12) / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)Marketed from Aug 29, 2019 | |
| 10144-342-16 | 10144034216 | 4 BLISTER PACK in 1 CARTON (10144-342-16) / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)Marketed from Dec 22, 2018 | |
| 10144-342-32 | 10144034232 | 8 BLISTER PACK in 1 CARTON (10144-342-32) / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)Marketed from Dec 22, 2018 | |
| 10144-342-60 | 10144034260 | 15 BLISTER PACK in 1 CARTON (10144-342-60) / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)Marketed from Dec 22, 2018 | |
| 10144-342-92 | 10144034292 | 23 BLISTER PACK in 1 CARTON (10144-342-92) / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)Marketed from Dec 22, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Inbrija
- Generic name (nonproprietary)
- levodopa
- Active ingredients
- Levodopa — 42 mg/1
- Dosage form
- Capsule
- Route
- Respiratory (Inhalation)
- Labeler
- Merz Pharmaceuticals, LLC
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 209184
- Marketing start
- Listing expires
- Other FDA classes
- Aromatic (Chemical structure)
- Identifiers
- Product ID 10144-342_03ec2066-f288-45cb-9919-c49fe175d8caSPL ID 03ec2066-f288-45cb-9919-c49fe175d8caSPL set ID a906f8e1-6e1c-480a-8276-c01bc65dd3beRxCUI 2107616, 2107621UNII 46627O600J
- Pharmacologic class
- Aromatic Amino Acid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N410144034204followed by a unit qualifier and the quantityPackage 10144-0342-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INBRIJA is indicated for the intermittent treatment of OFF episodes in patients with Parkinson's disease treated with carbidopa/levodopa. INBRIJA is an aromatic amino acid indicated for the intermittent treatment of OFF episodes in patients with Parkinson's disease treated with carbidopa/levodopa ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 209184
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Inbrijalevodopa | Levodopa 42 mg/1 | CapsuleRespiratory (Inhalation) | Merz Pharmaceuticals, LLC | 0259-6142 |